Umbrium en es it fr

Umbrium Brand names, Umbrium Analogs

Umbrium Brand Names Mixture

  • No information avaliable

Umbrium Chemical_Formula


Umbrium RX_link

Umbrium fda sheet

Umbrium msds (material safety sheet)

Umbrium MSDS

Umbrium Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Umbrium Molecular Weight

284.74 g/mol

Umbrium Melting Point


Umbrium H2O Solubility

Slightly soluble (50 mg/L)

Umbrium State


Umbrium LogP


Umbrium Dosage Forms

Tablets; Injectable solution

Umbrium Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Umbrium Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Umbrium Absorption

Essentially complete, with a bioavailability of 93%.

Umbrium side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Umbrium Patient Information

Umbrium Organisms Affected

Humans and other mammals